181 related articles for article (PubMed ID: 23331739)
1. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.
Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD
BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease.
Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH
Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284
[TBL] [Abstract][Full Text] [Related]
3. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
[TBL] [Abstract][Full Text] [Related]
4. Treatment of a Crohn's disease-related cutaneous facial lesion with topical tacrolimus.
Shah NP; Goel RM; Escudier M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):e71-3. PubMed ID: 25151593
[TBL] [Abstract][Full Text] [Related]
5. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial.
Hart AL; Plamondon S; Kamm MA
Inflamm Bowel Dis; 2007 Mar; 13(3):245-53. PubMed ID: 17206671
[TBL] [Abstract][Full Text] [Related]
7. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
8. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
10. Topical tacrolimus for recurrent penile Crohn's disease.
Sánchez L; Cabanillas M; Alvarez JC; Echarri A
J Crohns Colitis; 2014 Oct; 8(10):1145-6. PubMed ID: 24815787
[No Abstract] [Full Text] [Related]
11. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.
Braza TJ; DiCarlo JB; Soon SL; McCall CO
Br J Dermatol; 2003 Jun; 148(6):1242-4. PubMed ID: 12828755
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.
Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M
Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735
[TBL] [Abstract][Full Text] [Related]
14. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
15. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
17. Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study.
Hollar CB; Jorizzo JL
J Dermatolog Treat; 2004 Jan; 15(1):35-9. PubMed ID: 14754648
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids.
Poole CD; Chambers C; Allsopp R; Currie CJ
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):674-8. PubMed ID: 20565562
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
20. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Elad S; Or R; Resnick I; Shapira MY
Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
